Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic patients.

Abstract:

:We have measures serial carcinoembryonic antigen (CEA) titers in 92 patients, randomly selected from the patient population of a Radiotherapeutic Clinic, to correlate with clinical and follow-up evaluation. 57 out of 92 patients had positive CEA levels (2.5 ng/ml) or 62 percent of proven cancer patients. In this series, 67 percent (63/92) showed positive correlation between the curves of CEA levels and the clinical evaluation of disease activity. A simple computerized program was designed with the data collection directed to identifying parameters and trends of different groups. Breast CA showed 89 percent correlation; lung carcinoma showed 80 percent large bowel 75 percent, and other organs showed less. This assay is a prototype study of human response to therapy in relation to tumor antigen and host response, as measured by a nonspecific tumor associated antigen.

journal_name

Oncology

journal_title

Oncology

authors

Vider M,Kashmiri R,Hunter L,Moses B,Meeker WR,Utley JF,Maruyama Y

doi

10.1159/000224965

subject

Has Abstract

pub_date

1974-01-01 00:00:00

pages

257-72

issue

4

eissn

0030-2414

issn

1423-0232

journal_volume

30

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.

    abstract::The Abelson-virus-induced murine lymphosarcoma cell line RAW117-P and its in vivo selected highly malignant and metastatic variant RAW117-H10 have been studied for their growth in vivo, in vitro and in semi-solid agar. The highly malignant metastatic variant RAW117-H10 cells killed syngeneic Balb/c mice rapidly and fo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226473

    authors: Joshi SS,Sharp JG,Brunson KW

    更新日期:1987-01-01 00:00:00

  • Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study.

    abstract:BACKGROUND:Radioimmunotherapy (RIT) is effective in treating relapsed/refractory follicular lymphoma (FL), with durable remissions in first-line consolidation. We hypothesized that RIT with ibritumomab tiuxetan (Zevalin®) would result in durable remissions by eliminating minimal residual disease after cytoreduction. M...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000486788

    authors: Puvvada SD,Guillén-Rodríguez JM,Yan J,Inclán L,Heard K,Rivera XI,Anwer F,Mahadevan D,Schatz JH,Persky DO

    更新日期:2018-01-01 00:00:00

  • Long-Term Survival and Cure in Distant Metastatic Breast Cancer.

    abstract:BACKGROUND:Previous data showed that distant metastatic breast cancer (MBC) might be curable in up to 3% of the cases in selected patients, mostly young, with good performance status and with low-volume metastatic disease, mainly by an aggressive multidisciplinary approach including aggressive combination chemotherapy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000500298

    authors: Güth U,Elfgen C,Montagna G,Schmid SM

    更新日期:2019-01-01 00:00:00

  • Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.

    abstract:BACKGROUND:Clinical significance of immunohistochemically detectable level of p53 protein has been reported, but with some limitation as a prognosticator of bladder cancer patients. Whether or not simultaneous evaluation of mdm2 and p53 expression in bladder cancer exceed the prognostic significance of conventional his...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011971

    authors: Shiina H,Igawa M,Shigeno K,Yamasaki Y,Urakami S,Yoneda T,Wada Y,Honda S,Nagasaki M

    更新日期:1999-04-01 00:00:00

  • A dose escalation study of pegylated liposomal Doxorubicin (caelyx) in combination with capecitabine (xeloda) in patients with refractory solid tumors.

    abstract:OBJECTIVE:Pegylated liposomal doxorubicin (PLD) and capecitabine (CAP) have separately shown significant antitumor activity in a wide range of solid tumors. A phase I study was conducted in order to determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of their combination in patients with refr...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000090494

    authors: Maltezos E,Amarantidis K,Trichas M,Vasiliadis M,Toromanidou M,Chatzaki E,Karayiannakis A,Tsaroucha A,Romanidis K,Kakolyris S

    更新日期:2005-01-01 00:00:00

  • Endodermal sinus tumor of the ovary. Clinicopathologic study of 6 cases.

    abstract::6 cases of endodermal sinus tumor of the ovary are presented. In 4 patients pure endodermal sinus tumor was found microscopically. 1 patient had endodermal sinus tumor in one ovary and gonadoblastoma in the contralateral one. In another case endodermal sinus tumor was accompanied by an embryonal teratoma. Histological...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225338

    authors: Sikorowa L,Morawski A,Piatkowski Z

    更新日期:1979-01-01 00:00:00

  • Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.

    abstract::Twenty-two patients with metastatic breast carcinoma were treated with a combination of cisplatin (100 mg/m2 i.v. day 1) and etoposide (100 mg/m2 i.v. days 1-3). Eligible patients had measurable disease with normal organ functions, performance status < 3, age < 70 years and no previous chemotherapy for metastatic dise...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227364

    authors: Lluch A,Azagra P,Cervantes A,Muñoz M,Alberola V,Santabarbara P,García-Conde J

    更新日期:1994-07-01 00:00:00

  • From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

    abstract::Hepatocellular carcinoma (HCC) is characterized as a highly chemoresistant cancer with no effective systemic therapy. Despite surgical or locoregional therapies, prognosis remains poor because of high tumor recurrence or tumor progression, and currently there are no well-established effective adjuvant therapies. The m...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000111705

    authors: Pang RW,Poon RT

    更新日期:2007-01-01 00:00:00

  • DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.

    abstract:OBJECTIVE:Oncogene-driven stress-related DNA damage has been observed in lesions of colon cancer. Furthermore, DNA sensors and nucleases are stimulated during active DNA damage and replication. However, their changes and influences with respect to cancer remain largely unknown. METHODS:The gene expression levels of cG...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000452281

    authors: Yang CA,Huang HY,Chang YS,Lin CL,Lai IL,Chang JG

    更新日期:2017-01-01 00:00:00

  • Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.

    abstract::A number of therapeutic agents including L-asparaginase, Actinomycin-D, CCNU, Hydroxyurea, 5-FU, Cis-platinum, Cyclophosphamide, orchiectomy, Adriamycin and DES alone and in various combinations has been applied against the Dunning R-3327 rat prostatic adenocarcinoma subline G. We have found a parallel between the res...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225202

    authors: Block NL,Camuzzi F,Denefrio J,Troner M,Claflin A,Stover B,Politano VA

    更新日期:1977-01-01 00:00:00

  • Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature.

    abstract::Primary pancreatic lymphoma (PL) is an extremely rare disease, and large-scale studies are rarely performed even in Western countries, in which all cases of PL reported to date were of the B-cell type. Little information regarding PL is available in Japan. Nineteen cases of PL were collected through a nationwide study...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000058528

    authors: Nishimura R,Takakuwa T,Hoshida Y,Tsujimoto M,Aozasa K

    更新日期:2001-01-01 00:00:00

  • Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico.

    abstract:BACKGROUND:Variations in the incidence of cancer can be influenced by diet and specific lifestyles. In the last years, diet has been evaluated as an important factor in the development of ovarian cancer, even though the results have not been consistent. Dietary factors related to the risk of ovarian cancer in Mexican w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000063814

    authors: Salazar-Martinez E,Lazcano-Ponce EC,Gonzalez Lira-Lira G,Escudero-De los Rios P,Hernandez-Avila M

    更新日期:2002-01-01 00:00:00

  • Clinical staging of adult non-Hodgkin's lymphoma.

    abstract::In this study an attempt is made to propose a working clinical classification and staging of adult non-Hodgkin's lymphoma (NHL) which brings out both primary site and extent of disease. Unlike childhood NHL, where histopathology is uniformly of unfavourable type, this clinical staging system seems to have a prognostic...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226843

    authors: Lalitha N

    更新日期:1990-01-01 00:00:00

  • Presence of anti-gamma-FA-reactive antigens in spontaneous and carcinogen-induced malignancies of experimental animals.

    abstract::Immunochemical analysis of various tumors, representing 12 different tissue sites of origin, revealed a gamma-fetal antigen(gamma-FA)-like component in 17 of 23 malignant neoplasms of the mouse. This antigen was identified in extracts of spontaneous and carcinogen-induced murine tumors as well as in extracts of hepati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225584

    authors: Higgins PJ,Tong C,Borenfreund E

    更新日期:1981-01-01 00:00:00

  • Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature.

    abstract:OBJECTIVE:The aim of this study was to investigate the outcomes of gemcitabine-treated patients with inoperable biliary tract cancers. METHODS:We conducted a retrospective study of consecutively treated 22 inoperable biliary tract cancer patients with gemcitabine (500-1,000 mg/m(2) on days 1, 8, 15 every 4 weeks) as f...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000098109

    authors: Kiba T,Nishimura T,Matsumoto S,Hatano E,Mori A,Yasumi S,Doi R,Ikai I,Kitano T,Nishimura T,Yoshikawa K,Ishiguro H,Yanagihara K,Doi E,Teramukai S,Fukushima M

    更新日期:2006-01-01 00:00:00

  • Antitumorous and immunomodulatory effects of the Viscum album L. preparation Isorel.

    abstract::There are numerous data on the immunostimulative and antitumorous activity of various Viscum album tissue extracts. Isorel (Novipharm, Austria) is one of these compounds. We found that in mice an increased number of plaque-forming cells to sheep red blood cells (SRBC) followed the injection of Isorel together with SRB...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227217

    authors: Jurin M,Zarković N,Hrzenjak M,Ilić Z

    更新日期:1993-11-01 00:00:00

  • Early observations on the administration of Lonidamine in cancer patients.

    abstract::Lonidamine was studied in advanced cancer patients. The drug was given orally by single or repeated administrations. Single doses ranged from 150 to 450 mg. Repeated administrations were performed with progressively increasing doses: 450-900 mg daily. Lonidamine lacked severe toxic effects after both single and prolon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225891

    authors: Barduagni A,Barduagni M,Di Lauro L,Nardi M,Gallo Curcio C,Tonachella R,Ciottoli GB,Delle Chiaie S

    更新日期:1984-01-01 00:00:00

  • Characterization of physical binding between human papillomavirus 18 protein E7 and centromere protein C.

    abstract::Human papillomaviruses (HPVs) have been linked to a variety of human diseases, most notably cancer of the cervix. In the majority of cases, HPV proteins E6 and E7 are continuously expressed and bind a variety of cellular proteins. The precise mechanism of HPV-induced carcinogenesis has not been fully elucidated; there...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000322188

    authors: Yaginuma Y,Yoda K,Ogawa K

    更新日期:2010-01-01 00:00:00

  • Localisation of Hodgkin's disease and lymphomas by 67-gallium substraction scanning.

    abstract::67Ga-subtraction scan was found to be useful and a promising new method for the pre-treatment evaluation of the patient with Hodgkin's disease or non-Hodgkin's lymphoma. The scan appeared to be most accurate in the neck, chest, and axillary regions. It appears to offer a means of increasing the accuracy of evaluating ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225217

    authors: Krolikiewicz H,Maruyama Y,Deland FH,Beihn RM,Hafner T,Utley JF

    更新日期:1977-01-01 00:00:00

  • Treatment of advanced primary lung cancer associated with malignant pleural effusion by the combination of immunotherapy and chemotherapy.

    abstract::Twelve patients with advanced primary lung cancers associated with malignant pleural effusion were treated with intrathoracic instillation of recombinant interleukin-2 with or without in-vitro-sensitized cells. Two cases achieved complete response, and 7 partial response. The adverse effects seen in the protocol were ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227317

    authors: Miyao H,Chou T,Ito K,Moriyama H,Mitsuma S,Wakabayashi M,Yoshizawa H,Arakawa M

    更新日期:1994-01-01 00:00:00

  • Is capecitabine efficacious in triple negative metastatic breast cancer?

    abstract:BACKGROUND:Recent data suggest that capecitabine may have little efficacy in women with metastatic triple negative breast cancer (TNT). We have therefore retrospectively analysed capecitabine outcome in the TN subgroup of patients with locally advanced or metastatic breast cancer treated in our unit. PATIENTS AND METH...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000323175

    authors: Kotsori AA,Dolly S,Sheri A,Parton M,Shaunak N,Ashley S,Walsh G,Johnston S,Smith IE

    更新日期:2010-01-01 00:00:00

  • Animal models in drug development: historical aspects.

    abstract::The historical aspects of drug development and evaluation are anecdotically related. Clinical trials have proven the effectiveness of animal tests in the vast majority of cases, and the effort has been well spent. Similar of more noteworthy success may be obtainable with model systems in the study of prostatic cancer....

    journal_title:Oncology

    pub_type: 历史文章,杂志文章

    doi:10.1159/000225197

    authors: Gaunt R

    更新日期:1977-01-01 00:00:00

  • Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.

    abstract:PURPOSE:There is no standard second-line therapy for patients with oesophagogastric cancer who progress following first-line chemotherapy for advanced disease or relapse following radical multi-modality therapy. The aim of this retrospective study was to evaluate survival following rechallenge with platinum plus fluoro...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000322114

    authors: Okines AF,Asghar U,Cunningham D,Ashley S,Ashton J,Jackson K,Hawkes E,Chau I

    更新日期:2010-01-01 00:00:00

  • Significance of vitamins in cancer.

    abstract::The relationship of vitamins to cancer is very complex. Three types of interactions are possible: the effect of vitamins on tumor growth, the effect of tumors on vitamin metabolism, and the effect of vitamins on chemical carcinogens and anti-tumor chemotherapeutic agents. The significance of vitamins with particular r...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000225139

    authors: Basu TK

    更新日期:1976-01-01 00:00:00

  • Phase II evaluation of Ly156758 in metastatic breast cancer.

    abstract::Fourteen patients with disseminated breast cancer with primary or secondary resistance to tamoxifen were treated with LY156758. There were no complete or partial responses and 1 patient showed a minor response. These data illustrate that LY156758 did not have significant antitumor activity in patients previously treat...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226637

    authors: Buzdar AU,Marcus C,Holmes F,Hug V,Hortobagyi G

    更新日期:1988-01-01 00:00:00

  • Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial).

    abstract::We conducted a prospective multicenter phase II trial of patients with borderline resectable pancreatic carcinoma to investigate the efficacy of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival (OS). The clinical trial primarily evaluated OS time from the first day of protocol therapy as a prima...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000478660

    authors: Okada KI,Shimokawa T,Hirono S,Kawai M,Sho M,Satoi S,Matsumoto I,Eguchi H,Murakami Y,Yamada S,Doi M,Yamaue H,NAC-GA investigators.

    更新日期:2017-01-01 00:00:00

  • Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in pre-menopausal breast cancer patients.

    abstract::Many patients on cytotoxic chemotherapy show reduced frequency of menstrual bleeding due to a reduction in ovarian follicular activity. The endocrine perturbations related to these changed menstrual patterns were studied in detail. Nineteen regularly menstruating patients with primary breast cancer were given either c...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226930

    authors: Dowsett M,Richner J

    更新日期:1991-01-01 00:00:00

  • Targeting Developmental Pathways: The Achilles Heel of Cancer?

    abstract::Developmental pathways (e.g., Notch, Hippo, Hedgehog, Wnt, and TGF-β/BMP/FGF) are networks of genes that act co-ordinately to establish the body plan, and disruptions of genes in one pathway can have effects in related pathways and may result in serious dysmorphogenesis or cancer. Interestingly, all developmental path...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000478703

    authors: Dempke WCM,Fenchel K,Uciechowski P,Chevassut T

    更新日期:2017-01-01 00:00:00

  • Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.

    abstract:BACKGROUND:Identification of high-risk stage II colorectal cancer (CRC) patients, potential candidates for adjuvant chemotherapy, is challenging. Current clinical guidelines rely mainly on histopathological markers with relatively weak prognostic value. This motivates further search for prognostic markers. METHODS:Thi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000507118

    authors: Dimberg J,Andersson RE,Haglund S

    更新日期:2020-01-01 00:00:00

  • Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.

    abstract:INTRODUCTION:Breast cancer is one of the leading causes of death worldwide and is the result of dysregulation of various signaling pathways in mammary epithelial cells. The mortality rate in patients suffering from breast cancer is high because the tumor cells have a prominent invasive capacity towards the surrounding ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000501802

    authors: González-González L,González-Ramírez R,Flores A,Avelino-Cruz JE,Felix R,Monjaraz E

    更新日期:2019-01-01 00:00:00